Profil
Edwin P.
Ching is the founder of Emiliem, Inc. He previously worked as a Patent Counsel at GangaGen, Inc. and as a Vice President-Intellectual Property at EOS Biotechnology, Inc. He holds a doctorate degree from the California Institute of Technology, an undergraduate degree from the University of California, Berkeley, and a graduate degree from Columbia Law School.
Aktive Positionen von Edwin P. Ching
| Unternehmen | Position | Beginn |
|---|---|---|
Emiliem, Inc.
 Emiliem, Inc. BiotechnologyHealth Technology Emiliem, Inc. develops drugs for the treatment of cancer. The firm is particularly interested in diagnostic markers for rare diseases and the computational aspects of predicting both positive and negative patient outcomes. The company was founded by James E. Burden and Sucha Sudarsanam in 2005 and is headquartered in Berkeley, CA. | Gründer | - |
Ehemalige bekannte Positionen von Edwin P. Ching
| Unternehmen | Position | Ende |
|---|---|---|
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Corporate Officer/Principal | - |
GangaGen, Inc.
 GangaGen, Inc. BiotechnologyHealth Technology GangaGen, Inc. develops novel therapies for veterinary and agricultural applications. It focuses on the discovery and development of novel therapeutics for the prevention and treatment of infectious diseases, particularly infections that are resistant to antibiotics. The company was founded by Janakiraman Ramachandran on September 23, 2000 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Ausbildung von Edwin P. Ching
| California Institute of Technology | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
GangaGen, Inc.
GangaGen, Inc. BiotechnologyHealth Technology GangaGen, Inc. develops novel therapies for veterinary and agricultural applications. It focuses on the discovery and development of novel therapeutics for the prevention and treatment of infectious diseases, particularly infections that are resistant to antibiotics. The company was founded by Janakiraman Ramachandran on September 23, 2000 and is headquartered in Palo Alto, CA. | Health Technology |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Health Technology |
Emiliem, Inc.
Emiliem, Inc. BiotechnologyHealth Technology Emiliem, Inc. develops drugs for the treatment of cancer. The firm is particularly interested in diagnostic markers for rare diseases and the computational aspects of predicting both positive and negative patient outcomes. The company was founded by James E. Burden and Sucha Sudarsanam in 2005 and is headquartered in Berkeley, CA. | Health Technology |
